Accordingly, TG2-mediated deamidation of gluten in vivo should be a rare event, which agrees poorly with the observation of rapid CD4+ T cell response to deamidated gluten upon oral gluten challenge of treated CeD patients [7, 8]. This evidence concerns the gene TGM2 and cranioectodermal dysplasia.